Clinical Trial Update: Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer [NA]

View source ↗

Summary

Study evaluating whether metformin reduces the levothyroxine dose required to suppress TSH in differentiated thyroid cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Levothyroxine (levothyroxine)
• metformin (metformin)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Malignant Neoplasm of Thyroid Stage I, Malignant Neoplasm of Thyroid Stage II | NA | Status: COMPLETED